Cellebrite Di Ltd (CLBT)

$10.47 0.09 (0.87%)

16:00 EDT CLBT Stock Quote Delayed 30 Minutes

The 7 Best Stocks Under $10 to Buy in May

By Josh Enomoto, InvestorPlace Contributor May 3, 2023

While quality matters in the market, these best stocks under $10 to buy gives you some potential diamonds in the rough.

7 Tech Stocks to Buy for the Next Decade

7 Tech Stocks to Snatch Out of the Bargain Bin

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 503,973

Day's Range $10.37 - $10.53

52-Week Range $5.22 - $12.50

Dividend & Yield N/A (N/A)

CLBT Stock Predictions, Articles, and Cellebrite Di Ltd News

From the Web

(NASDAQ:CLBT)

From Seeking Alpha Feb 15, 2024

Cellebrite surpasses expectations with strong Q4 results, including increased revenue and annual recurring revenue, setting a positive outlook for 2024.

Cellebrite Non-GAAP EPS of $0.05 beats by $0.03, revenue of $76.68M beats by $4.16M (NASDAQ:CLBT)

From Seeking Alpha Aug 8, 2023

Cellebrite press release (CLBT): Q2 Non-GAAP EPS of $0.05 beats by $0.03.Revenue of $76.68M (+22.6% Y/Y) beats by $4.16M.“Based on our results to date and the anticipated trajectory...

Cellebrite Non-GAAP EPS of $0.03 beats by $0.01, revenue of $71.23M beats by $1.79M (NASDAQ:CLBT)

From Seeking Alpha May 10, 2023

Cellebrite press release (CLBT): Q1 Non-GAAP EPS of $0.03 beats by $0.01.Revenue of $71.23M (+14.2% Y/Y) beats by $1.79M.Subscription revenue of $61.3 million, up...

Cellebrite Non-GAAP EPS of $0.08 beats by $0.01, revenue of $74.02M misses by $0.51M (NASDAQ:CLBT)

From Seeking Alpha Feb 15, 2023

Cellebrite press release (CLBT): Q4 Non-GAAP EPS of $0.08 beats by $0.01.Revenue of $74.02M (+9.0% Y/Y) misses by $0.51M.Annual Recurring Revenue (ARR) of $249 million, up...

Cellebrite Non-GAAP EPS of $0.01 misses by $0.01, revenue of $71.68M misses by $0.45M (NASDAQ:CLBT)

From Seeking Alpha Nov 17, 2022

Cellebrite press release (CLBT): Q3 Non-GAAP EPS of $0.01 misses by $0.01.Revenue of $71.68M (+8.8% Y/Y) misses by $0.45M.Annual Recurring Revenue (ARR) of $232 million, up...

J.P. Morgan Reaffirms Their Buy Rating on Cellebrite DI (CLBT)

From TipRanks Aug 16, 2022

In a report released on August 11, Doug Bruehl from J.P. Morgan maintained a Buy rating on Cellebrite DI (CLBT – Research Report), with a price target of $9.0...

ADVERTISEMENT